Skip to main content
. 2023 Oct 9;12(19):6417. doi: 10.3390/jcm12196417

Figure 1.

Figure 1

Annual exacerbation and hospitalization rates in the groups of patients, according to the blood eosinophil count in both groups (with and without inhaled corticosteroid treatment). Those patients under inhaled corticosteroid treatment and more than 300 eosinophils/µL presented a significant decrease in the annual exacerbation rate compared with patients without eosinophilia. Eos: eosinophils.